Feature | EP Lab | April 12, 2021

Medtronic Recalls its ICDs and CRT-Ds Due to Risk of Rapid Battery Depletion

Class I recall includes Evera, Viva, Brava, Claria, Amplia, Compia and Visia implantable cardioverter defibrillators and cardiac resynchronization therapy devices

Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.

April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.

If the user does not respond to the first warning, the device may stop functioning, Medtronic said. The likelihood that this issue will occur is constant after approximately three years. after device use.

The U.S. Food and Drug Administration (FDA) issued a a notice April 12 that identified this as a class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. The FDA said there have been 444 complaints regarding these devices. There are 264 medical device reports, with 18 injuries including people experiencing bradycardia (slow heart rhythm) or heart failure symptoms. The FDA said no deaths have been reported.

The recall includes Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia and Visia ICDs and CRT-Ds distributed between Aug. 31, 2012 to May 9, 2018.This includes 239,171 devices in the United States. The FDA said Medtronic first issued the recall Feb. 3, 2021.

Patient and Clinician Guidenace on the Medtronic ICD Recall

On Feb. 3, 2021, Medtronic sent an urgent medical device correction letter to all affected healthcare professionals. The letter gave the following information:

Patient Management Guidance:
   • Continue normal follow-up per local clinical protocol.
   • Data suggests that battery failure is less common in patients who use the battery most, such as for frequent pacing support and higher voltage therapy.
   • Where possible, take advantage of the CareLink™ home monitoring system and the wireless low battery voltage CareAlert.
   • The low battery voltage audible alert is shipped ‘On’ with high-urgency tones; Remind patients to contact their clinic if they hear an audible alert, particularly since they may be opting to delay clinic visits due to COVID-19 guidance.
   • Inform a Medtronic representative of any unexpected device behaviors.
   • Be aware that the inability to operate the device, or transmit data, may be an indicator that the device has experienced this issue.

If unexpected recommended replacement time (RRT) is observed, prompt replacement of the device should occur with the underlying clinical situation of the patient:
   • For non-pacing dependent patients or for primary prevention ICD patients, replacement within one week of an unexpected RRT notification is recommended.
   • For pacing dependent patients, immediate replacement is recommended following an unexpected RRT notification. Note: For all patients, this issue can also manifest as an unexpected change in the remaining longevity estimate cannot be attributed to programming changes, or changes in use conditions.

The Medtronic letter also stated:
   • Medtronic medical staff in consultation with the Independent Physician Quality Panel recommends against replacing the device due to the low rate of occurrence and the low risk for permanent harm if immediate replacement occurs in response to an unexpected RRT.
   • Patients and clinicians may determine if a specific device is affected by looking up the serial number on Medtronic’s product performance website at http://wwwp.medtronic.com/productperformance/
   • Clinicians also should also complete a clinician confirmation certificate (included with the correction letter) and return via email to [email protected]
   • Notify Medtronic of any adverse events or quality problems associated with your use of this product.
   • Customers with questions should contact their local Medtronic representative or Medtronic technical services at 800-723-4636, or [email protected]

Full List of Affected Devices in Medtronic ICD and CRT-D Recall:

   • Evera and Visia
   • Viva, Claria, Amplia, Compia and Brava

 

Find more EP lab news

Find more new on ICD technology

 

Related Content

BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.

BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.

News | Cardiac Resynchronization Therapy Devices (CRT) | August 03, 2021
August 3, 2021 — In association with Heart Rhythm 2021, Biotro
News | Cardiac Resynchronization Therapy Devices (CRT) | March 03, 2021
March 3, 2021 — Medtronic announced new results from the landmark...
Left bundle branch (LBBP) activation imaging shown using wall motion color codes on echo imaging from Canon. #HRS2020 #heartrhythm2020

Left bundle branch (LBBP) activation imaging shown using wall motion color codes on dyamic echo imaging from Canon. 

News | Cardiac Resynchronization Therapy Devices (CRT) | May 13, 2020
May 13, 2020 —...
Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | March 09, 2020 | Valentina Kutyifa M.D., Ph.D.
Cardiovascular disease is the leading cause of death for women in North America, and women with...
His Corrective Pacing Effective as an Initial Strategy for Heart Failure Cardiac Resynchronization CRT therapy vs. biventricular pacing (BiV) as a first-line strategy. #HRS #HRS19 #HRS2019
News | Cardiac Resynchronization Therapy Devices (CRT) | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — A pilot trial has shown His pacing in...
Biotronik Launches Acticor DX and CRT-DX Devices in U.S.
News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019
Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices....
Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe
News | Cardiac Resynchronization Therapy Devices (CRT) | April 18, 2019
Biotronik announced the European market release of what it calls the world’s smallest implantable cardioverter...
Medtronic AdaptivCRT Feature Associated with Improved Heart Failure Patient Survival
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved patient survival....
Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery
News | Cardiac Resynchronization Therapy Devices (CRT) | February 26, 2018
The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain implantable cardioverter...